围术期医学标准化终点(StEP)倡议:肾脏终点的系统综述与共识定义
该系统综述与共识通过检索围术期临床试验中肾脏终点的报告情况,并结合多轮Delphi共识流程,最终推荐4个肾脏结局指标用于围术期临床试验。系统综述纳入63项研究,发现终点定义异质性大且不精确。
要点
- 推荐使用KDIGO标准定义急性肾损伤。
- 推荐术后30天eGFR较基线下降≥30%定义急性肾脏病(限术后7天内符合AKI标准者)。
- 推荐死亡或肾脏替代治疗复合终点及MAKE复合终点。
核心结论
- 识别出4个关键肾脏结局指标,建议用于围术期临床试验。
- 使用标准化定义捕获和报告这些终点将促进未来试验的基准比较与荟萃分析。
研究设计与样本
- 系统综述检索围术期临床试验中报告的肾脏终点,纳入63项研究进行分析。
- 基于肾脏主题组专业经验制定初始候选终点列表,采用多轮Delphi共识流程精炼列表。
- Delphi第1、2、3轮响应率分别为89%(n=16)、90%(n=75)、100%(n=6)。
主要发现
- 系统综述纳入的63项研究中,终点定义存在明显异质性和不精确性。
- 初始候选终点列表包含10个终点供考虑。
- 最终确定4个肾脏终点:KDIGO定义的急性肾损伤、术后30天eGFR较基线下降≥30%定义的急性肾脏病、死亡或肾脏替代治疗复合终点、MAKE复合终点。
关键数值与推荐
- 急性肾损伤采用KDIGO共识标准定义。
- 急性肾脏病定义为术后30天eGFR较基线下降≥30%,且患者术后7天内符合急性肾损伤标准。
- 复合终点包括死亡或肾脏替代治疗,以及MAKE复合终点。
临床怎么用
- 围术期临床试验应优先考虑使用这4个标准化肾脏终点。
- 采用统一终点定义可提高试验间可比性并支持荟萃分析。
局限性
- 系统综述观察到终点定义存在明显异质性和不精确性。
- Delphi各轮响应率虽较高,但第3轮样本量较小(n=6)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Renal injury is a common perioperative complication. The adoption of renal endpoints, standardised and valid for use in perioperative clinical trials, would enhance the quality of perioperative clinical research. The Standardised Endpoints in Perioperative Medicine (StEP) initiative was established to derive standardised endpoints for use in perioperative clinical trials. METHODS: A systematic review was conducted to identify renal endpoints currently reported in perioperative clinical trials. In parallel, an initial list of candidate endpoints was developed based on renal theme group expertise. A multi-round Delphi consensus process was used to refine this list and produce a suite of recommended perioperative renal outcome measures. RESULTS: Based on our systematic review, 63 studies were included for analysis. Marked heterogeneity and imprecision of endpoint definitions were observed. Our initial list of candidate endpoints included 10 endpoints for consideration. The response rates for Delphi rounds 1, 2, and 3 were 89% (n=16), 90% (n=75), and 100% (n=6), respectively. A final list of four renal endpoints was identified: acute kidney injury defined by the Kidney Disease: Improving Global Outcomes (KDIGO) consensus criteria, acute kidney disease defined by ≥30% decline in estimated glomerular filtration rate from baseline at 30 days after operation in patients meeting the acute-kidney-injury criteria within 7 days of surgery, the composite of death or renal replacement therapy, and the Major Adverse Kidney Events (MAKE) composite. CONCLUSIONS: We identified four key renal outcome measures that should be considered for use in perioperative clinical trials. Using standardised definitions to capture and report these endpoints will facilitate improved benchmarking and meta-analysis of future trials.
引用
- McIlroy DR, Bellomo R, Billings FT, et al. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: renal endpoints. Br J Anaesth. 2018. PMID: 30336845. doi:10.1016/j.bja.2018.08.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。